ETH Zurich researchers built an implant with a gold-and-platinum catalyst that converts excess blood glucose into gluconate, switched on wirelessly when a sensor detects high sugar. In diabetic mice it regulated blood sugar for six weeks.
The World Health Organization has issued its first guidelines on treating obesity in children and adolescents, putting diet, activity and behavior support first and limiting medicines and surgery to teenagers.
In a Vanderbilt pilot study of 16 women with obesity and prediabetes, empagliflozin reduced blood cell clumps linked to heart disease within two weeks. Women on a low-calorie diet did not show the drop. A larger placebo-controlled trial is now enrolling.